Ketamine Assisted Psychotherapy

The two available formulations of Ketamine are Spravato (eskatemine) and compounded Ketamine (racemic mixture).  Spravato is FDA approved and compounded Ketamine is used "off-label".

Ketamine is a DEA Schedule III medication that has long been used safely as an anesthetic and analgesic agent and now, often effectively for treatment of depression, alcoholism, substance dependencies, PTSD and other psychiatric diagnoses. 

Ketamine is classified as a dissociative anesthetic, dissociation meaning a sense of disconnection from one’s ordinary reality and usual self. At the dosage level administered to you, you will most likely experience mild anesthetic, anxiolytic, anti-depressant and, potentially, psychedelic effects. Non-ordinary (“altered”), transpersonal (“transcendental”, “mystical”, “spiritual”, “religious”) peak experiences often occur. Research has demonstrated the possibility of an antidepressant response to low doses of ketamine– administered intravenously or intramuscularly. The antidepressant effect tends to be more sustained with repeated use—in other words, a cumulative effect. 

The length of ketamine effect is typically about one hour. You will be mostly internally focused for the first 30 minutes to one hour or possibly longer.  The formulation of Ketamine will be decided on with your provider.  Inquire today to see if Ketamine is an option for you. 

The patient's options will be discussed at the first appointment.  Prices range depending on treatment selection.  Inquire for more information.

Check out no interest financing options below:

Advanced Care Card

Credit: Integrative Psychiatric Institute

Learn More:

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653702/

https://www.sciencedirect.com/science/article/abs/pii/S0149763421002086?via%3Dihub

https://doi.org/10.1080/02791072.2019.1587556